<sup>18</sup>F-labeled prostate-specific membrane antigen-1007 uptake in a patient with metastatic pheochromocytoma

We present the case of a 59-year-old male patient with progressive metastatic adrenal pheochromocytoma.The patient had no significant family history of genetic disorders, and the pheochromocytoma was deemed sporadic in origin.Three years prior, he underwent radical nephrectomy and adrenalectomy, and his disease began progressing one year ago.Recently, he exhibited no significant response following targeted therapies including Sunitinib, Bevacizumab, and 131 I-meta-iodobenzylguanidine.The multidisciplinary team recommended multi-gene mutation testing; however, the patient declined due to financial constraints, as the cost was not covered by medical insurance.The patient undergone